Fruquintinib in the Treatment of Soft Tissue Sarcoma
NCT05142631
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Soft Tissue Sarcoma
Interventions
DRUG:
Fruquintinib
Sponsor
Fudan University